Equivalence of family functioning and externalizing behaviors in adolescent substance users of different race/ethnicity.
Equivalence of family functioning and externalizing behaviors in adolescent substance users of different race/ethnicity.
复制标题
DOI：
10.1016/j.jsat.2010.01.010
复制
发表时间：
2010-06
影响因子：
3.9
通讯作者：
Szapocznik J
中科院分区：
文献类型：
--
作者：
Feaster DJ;Robbins MS;Henderson C;Horigian V;Puccinelli MJ;Burlew AK;Szapocznik J
针对青少年药物滥用的简短战略家庭治疗（BSFT）临床试验对480名12至17岁的青少年男孩和女孩及其父母进行了设计，以最大限度地增加西班牙裔和黑人青少年被纳入的机会，以便进行有效的亚组比较。检验测量不变性是保证分析有效的重要步骤。两个对试验结果分析很重要的构建领域，青少年问题行为和家庭功能显示出高度的测量不变性，这允许有效地比较各组之间的平均基线差异。结果表明，与西班牙裔和非西班牙裔白人家庭相比，黑人家庭的初始家庭功能水平明显较高，青少年外化水平明显较低。这种模式与有更严重问题的黑人青少年转介到限制环境而不是门诊药物滥用治疗的可能性增加相一致。这种可能性强调了在评估不同治疗效果以防止混淆之前考虑不同亚组基线特征的重要性。
Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial of 480 adolescents boys and girls age 12 to 17 and their parents was designed to maximize the chance that a sufficient number of Hispanic and Black adolescents would be included to allow valid subgroup comparisons. Examination of measurement invariance is an important step to ensure valid analysis. Two construct areas important to the analysis of trial results, adolescent problem behaviors and family functioning showed a high degree of measurement invariance, which allowed valid comparisons of mean baseline differences across groups. Results showed that Black families had significantly higher initial levels of family functioning and lower levels of adolescent externalizing than either Hispanic or White non-Hispanic families. This pattern is consistent with an increased likelihood of referral of Black adolescents with more severe problems to restricted setting rather than to outpatient drug abuse treatment. This possibility highlights the importance of considering differing baseline characteristics of subgroups prior to assessing differential treatment effectiveness to prevent confounding.
登录
查看更多内容
影响因子：
2.1
作者：
Leiber, Michael J.;Johnson, Joseph D.
通讯作者：
Johnson, Joseph D.
影响因子：
2.7
作者：
Meyers, Kathleen;Hagan, Teresa A.;Frantz, Jeanne
通讯作者：
Frantz, Jeanne
DOI：
10.1080/10705510701301834
发表时间：
2005-01-01
影响因子：
6
作者：
Chen, FF;Sousa, KH;West, SG
通讯作者：
West, SG
DOI：
10.1191/1740774504cn041oa
发表时间：
2004-01-01
期刊：
Clinical trials (London, England)
影响因子：
--
作者：
Feaster, Daniel J;Robbins, Michael S;Szapocznik, Jose
通讯作者：
Szapocznik, Jose
影响因子：
5.5
作者：
Leiber, Michael J.;Johnson, Joseph;Lacks, Robyn
通讯作者：
Lacks, Robyn